SEPN

AS OF

Feb 3 closing price

Price

$25.54

Change

+$0.51 (+2.04%)

Capitalization

1.12B

50 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

SEPN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Septerna (SEPN) Ownership - Who owns Septerna?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

SEPN

Capitalization

1.12B

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

474M

Total Cash/Share

10.59

Total Debt

24.1M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.49%

Revenue

22M

ROE

N/A

Book Value

389M

P/B Ratio

2.88

Cash Flow

N/A

Earnings

-6.9

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

45K

Current Ratio

6.53

Current Revenue Per Employee

286600.00

Dividends Per Share - Security

N/A

EBITDA

-87.9M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-15.06

Shares Held By Institutions

1.1B

Shares Outstanding - Current

44.8M

Total Liabilities

218M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-10.222

View a ticker or compare two or three

Compare

SEPN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SEPN showed earnings on November 10, 2025. You can read more about the earnings report here.

View AI-Driven Trading for SEPN

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details